Physician profile
Amber Treuting
NPI 1093465106
$2,488.04
in general payments reported to CMS, 2019-2025
23 companies · $843 in 2025
The $843 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $218 · 2023: $582 · 2024: $846 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $419.51 | 2023-2025 | Belbuca |
| Nevro Corp. | $309.23 | 2022-2024 | Senza |
| Abbott Laboratories | $308.68 | 2023-2025 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $292.90 | 2022-2025 | Relistor |
| Boston Scientific Corporation | $213.01 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $189.98 | 2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $157.24 | 2025 | Senza |
| Biotronik Nro, INC. | $111.00 | 2025 | Prospera |
| Ibsa Pharma INC. | $103.15 | 2022-2023 | Tirosint, Licart |
| Saluda Medical Americas, INC. | $98.12 | 2024-2025 | Evoke |
| Virtus Pharmaceuticals LLC | $36.91 | 2025 | Levorphanol Tartrate |
| Si-Bone, INC. | $32.05 | 2024 | |
| Nalu Medical, INC. | $28.27 | 2023 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $25.16 | 2023 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $22.17 | 2023 | Qutenza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $21.39 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.00 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $19.22 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.12 | 2025 | |
| Advanced Oxygen Therapy INC. | $17.24 | 2025 | Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $16.10 | 2025 | Durolane |
| Astrazeneca Pharmaceuticals LP | $14.13 | 2022 | |
| Hydrocision, INC. | $13.46 | 2025 | Tenjet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Treuting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.